Adrenomyeloneuropathy
ICD-10: E71.522ORPHA: 139399
Overview
Adrenomyeloneuropathy (AMN) is an adult form of the peroxisomal disease X-linked adrenoleukodystrophy (X-ALD, see this term), characterized by spastic paraparesia and often associated with peripheral adrenal insufficiency in males
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with Adrenomyeloneuropathy, sourced from HPO and Orphanet clinical annotations.
Peripheral axonal degenerationAbnormal spinal cord morphologyDistal sensory impairmentAbnormal circulating fatty-acid concentrationProgressive spastic paraparesisDistal lower limb muscle weaknessAbnormality of peripheral nervous system electrophysiologyImpaired continenceAxonal degenerationAdrenocortical abnormalityAbnormality of skin pigmentationSpasticityHyperreflexiaSpastic gaitFine hairBowel incontinenceUrinary bladder sphincter dysfunctionBabinski signAtrophy of the spinal cordDorsal column degenerationCerebral dysmyelinationAtrophy/Degeneration involving the corticospinal tractsVery long chain fatty acid accumulationLeg muscle stiffnessPeripheral neuropathyIntra-oral hyperpigmentationAdrenocorticotropic hormone excessFatigueFemale sexual dysfunctionAbnormal libidoMale sexual dysfunctionDelayed somatosensory central conduction timeErectile dysfunctionLip hyperpigmentationBrain imaging abnormalityUrinary urgencyUrinary retentionUrinary incontinenceAtypical behaviorAdrenal insufficiencyDysarthriaFrontal baldingMemory impairmentBack painFunctional motor deficitPrimary adrenal insufficiencyDysesthesiaDecreased circulating vitamin B12 concentrationCognitive impairment
Classification & Codes
ICD-10 Code
E71.522Orphanet Code
ORPHA:139399Adrenomyeloneuropathy
| ICD-10 | E71.522 |
| Orphanet | ORPHA:139399 |
| Treatments | 0 drug(s) |
| Symptoms on record | 49 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO